Scientists discover proteins that could help fight cancer, slow ageing
Researchers at the Children's Medical Research Institute (CMRI) in Sydney discovered that these proteins play a crucial role in controlling telomerase -- an enzyme responsible for protecting DNA during cell division, Xinhua news agency reported.
The breakthrough clarifies how telomerase both supports healthy ageing and fuels cancer cell growth, highlighting new possibilities for treatments that slow ageing or stop cancer by targeting these newly identified proteins, the team said.
Telomerase helps maintain the ends of chromosomes, known as telomeres, which are vital for genetic stability.
Telomerase adds DNA to the ends of chromosomes (telomeres) to protect them from damage.
While telomerase is essential for the health of stem cells and certain immune cells, cancer cells often exploit this enzyme to grow uncontrollably.
CMRI Researchers have now identified a new set of proteins that play a vital role in controlling this enzyme.
In the paper published in the journal Nature Communications, the team highlighted that three proteins -- NONO, SFPQ, and PSPC1 -- guide telomerase to chromosome ends; disrupting them in cancer cells prevents telomere maintenance, potentially stopping cancer cell growth. 'Our findings show that these proteins act like molecular traffic controllers, making sure telomerase reaches the right destination inside the cell,' said Alexander Sobinoff, the lead author of the study.
'Without these proteins, telomerase can't properly maintain telomeres, a finding which has significant implications for healthy aging and cancer progression,' Sobinoff added. Hilda Pickett, head of CMRI's Telomere Length Regulation Unit and the study's senior author, noted that understanding how telomerase is controlled opens new possibilities for developing treatments targeting cancer, ageing, and genetic disorders linked to telomere dysfunction.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
18 hours ago
- Time of India
India, Australia launch research project to bolster undersea surveillance
NEW DELHI: In a landmark agreement in defence cooperation, India and Australia have initiated a research project to enhance undersea surveillance capabilities, focusing on early detection and tracking of submarines and autonomous underwater vehicles. As per Australia's Department of Defence, the agreement outlines a three-year joint project between Australia's Defence Science and Technology Group (DSTG's) Information Sciences Division and India's Defence Research and Development Organisation (DRDO's) Naval Physical and Oceanographic Laboratory. The DSTG is a leading Australian govt agency, employing one of the largest number of scientists and engineers, who deliver advice and innovative solutions on matters of defence science and technology. The Department of Defence said the research project would explore the use of towed array target motion analysis technology to improve the reliability, efficiency and interoperability of current surveillance capabilities. DSTG senior researcher Sanjeev Arulampalam explained that a towed array consists of a long linear array of hydrophones, towed behind a submarine or surface ship on a flexible cable. 'We need to harness the best minds in innovation, science and technology to build new capabilities, to innovate at greater pace, and to strengthen our strategic partnerships. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Why seniors are rushing to get this Internet box – here's why! Techno Mag Learn More Undo The hydrophones work together to listen to the undersea environment from various directions,' the Department of Defence cited Dr Arulampalam as saying. The project is the latest milestone in increasing maritime domain awareness cooperation between Australia and India. It is significant within the Quad framework— consisting of India, Australia, US and Japan — which seeks to counter China's growing maritime belligerence in the Indo-Pacific. The combination of target motion analysis with the towed array system is intended to manage noise corruption and explore performance improvements. The project would see novel algorithms being put to test, using the strengths and shared knowledge of the two countries. 'It will involve the sharing of ideas, investigation trials, algorithm demonstrations and performance analysis,' Arulampalam said. The Department of Defence announcement comes after external affairs minister S. Jaishankar met his Australian counterpart, Penny Wong, on the sidelines of the Quad foreign ministers' meeting in the US earlier this week.
The Hindu
a day ago
- The Hindu
Orthopaedic surgeon from Kalaburagi dist. found dead in UK
A 30-year-old orthopaedic surgeon, Rahul Ragate, hailing from Chimmanchod village of Chincholi taluk of Kalaburagi district, died under mysterious circumstances near a bridge in Gold Coast city in Sydney in Australia on Thursday. According to family sources and villagers, Rahul died on Thursday morning. As per the reports the passerby saw him swimming in the lake, who later drowned and did not resurface. The Queensland police have conducted search operations and recovered the Doctor's body; the exact cause of death can only be revealed only after the investigation. Dr. Rahul Ragate served as Trauma Registrar at University Hospitals Birmingham NHS Foundation trust in the United Kingdom before shifting to Australia recently. Sources close to the bereaved family said that former Bidar MP Bhagwant Khuba communicated with Australian High Commission in India and making all efforts to obtain necessary clearances to bring the mortal remains of the Dr. Ragate to India.
Indian Express
a day ago
- Indian Express
Lyssavirus is rare, but deadly — what should you do if bat bites you?
By Vinod Balasubramaniam A man in his 50s has died from lyssavirus in New South Wales after being bitten by a bat several months ago. This is Australia's fourth human case of bat lyssavirus and the first confirmed case in NSW since the virus was first identified in 1996 in a black flying fox in Queensland. So what is lyssavirus? And how can you protect yourself if you come into contact with a bat? Australian bat lyssavirus belongs to the Rhabdoviridae family, the same group of viruses that causes rabies. It primarily infects bats. Active monitoring suggests fewer than 1 per cent of healthy bats carry the virus, though prevalence rises to 5–10 per cent in sick or injured bats. In bats, the virus often causes no obvious symptoms, though some show neurological signs such as disorientation, aggression, muscle spasms and paralysis. Some will die. The virus has been confirmed in all four mainland flying fox species (Pteropus alecto, P. poliocephalus, P. scapulatus and P. conspicillatus) as well as the yellow-bellied sheathtail bat (Saccolaimus flaviventris), a species of microbat. However, serological evidence – where scientists test for antibodies in bats' blood – suggests other microbats could be susceptible too. So we should be cautious with all Australian bat species when it comes to lyssavirus. Unlike rabies, which causes roughly 59,000 human deaths annually, predominantly in Africa and Asia, human infection with bat lyssavirus is extremely rare. Australian bat lyssavirus, as the name suggests, is unique to Australia. But other bat lyssaviruses, such as European bat lyssavirus, have similarly caused rare human infections. Human infection with bat lyssavirus occurs through direct contact with infected bat saliva via bites, scratches or open skin. It can also occur if our mucous membranes (eyes, nose, mouth) are exposed to bat saliva. There's no risk associated with bat faeces, urine, blood, or casual proximity to roosts. If someone has been exposed, there's an incubation period which can range from weeks to more than two years. During this time the virus slowly moves through the body's nerves to the brain, staying hidden and symptom-free. Treating the virus during the incubation period can prevent the illness. But if it's not treated, symptoms are serious and it's invariably fatal. The nature of the illness in humans mirrors rabies, beginning with flu-like symptoms (fever, headache, fatigue), then quickly progressing to severe neurological disease, including paralysis, delirium, convulsions, and loss of consciousness. Death generally occurs within 1–2 weeks of symptom onset. All four recorded human cases in Australia – three in Queensland (in 1996, 1998 and 2013) and the recent NSW case – have been fatal. There's no effective treatment once symptoms develop If someone is potentially exposed to bat lyssavirus and seeks medical attention, they can be treated with post-exposure prophylaxis, consisting of rabies antibodies and the rabies vaccine. This intervention is highly effective if initiated promptly – preferably within 48 hours, and no later than seven days post-exposure – before the virus enters the central nervous system. But no effective treatment exists for Australian bat lyssavirus once symptoms develop. Emerging research on monoclonal antibodies offers potential future therapies, however these are not yet available. Pre-exposure rabies vaccination, involving three doses over one month, is recommended for high-risk groups. This includes veterinarians, animal handlers, wildlife rehabilitators, and laboratory workers handling lyssaviruses. It's important for members of the public to avoid all direct contact with bats. Only vaccinated, trained professionals, such as wildlife carers or veterinarians, should handle bats. Public education campaigns are essential to reduce risky interactions, especially in bat-populated areas. If you get bitten or scratched by a bat, it's vital to act immediately. Wash the wound thoroughly with soap and water for at least 15 minutes, apply an antiseptic (such as betadine), and seek urgent medical attention. This tragic case in NSW underscores that while extremely rare, bat lyssavirus is an important public health threat. We need to see enhanced public awareness and ensure vaccination for high-risk groups, alongside ongoing bat monitoring and research into new treatments.
